AtkinsRéalis to acquire Australia-based Engineering Consultancy WGA
MONTREAL, April 21, 2026 /CNW/ – AtkinsRéalis Group Inc. (TSX: ATRL), a world-class engineering services and nuclear company with offices around the world,... Read more.
Former MLB Players Lead Ember Sports Mobile App, Bringing Pro-Level Training to Athletes Everywhere
The MLB veterans say platform is a “game changer” for athletes at every level HUNTSVILLE, Ala., April 21, 2026 /PRNewswire/ — Sports technology... Read more.
AtkinsRéalis to acquire Australia-based Engineering Consultancy WGA
MONTREAL, April 21, 2026 /CNW/ – AtkinsRéalis Group Inc. (TSX: ATRL), a world-class engineering services and nuclear company with offices around the world,... Read more.
Cognizant Propels AI Workforce Training with Cognizant Skillspring™: New Talent Transformation Platform Designed to Accelerate Clients’ Workforce AI Readiness
New AI-native platform equips organizations to achieve AI fluency, aligns workforce capabilities with the demands of an AI-powered economy and drives outcome-based... Read more.
Toby Neugebauer Incredibly Bullish on Project Matador and Calls for Sale of Company to Maximize Shareholder Value
Toby Neugebauer Praises Team for Creating the Nation’s Most Attractive Power Asset Toby Neugebauer, His Immediate Family and Former Executives Hold ~40% of... Read more.
EQT raises Asia Pacific’s largest private equity fund, closing BPEA IX at USD 15.6 billion in total commitments
EQT BPEA IX oversubscribed; closes at USD 15.6 billion in total commitments BPEA IX is the largest Asia Pacific-dedicated private equity fund raised to date, with... Read more.
CCE 2026 Wrapped Up with Record-Breaking Global Participation and Innovation
SHANGHAI, April 20, 2026 /PRNewswire/ — The 27th China Clean Expo (CCE 2026), organized by Sinoexpo Informa Markets and supported by ISSA – The Worldwide... Read more.
Cadonilimab Combination Demonstrates Promising Survival Benefit in Locally Advanced Pancreatic Cancer: Phase II COMPASSION-26 Data Presented at AACR 2026
HONG KONG, April 20, 2026 /PRNewswire/ — Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) today announced that positive Phase II results... Read more.
Rznomics Reports Interim Clinical Data for RZ-001 in Hepatocellular Carcinoma at AACR 2026 Demonstrating Encouraging Efficacy and Favorable Safety Profile
– RECIST-based ORR of 38.5% (confirmed) and 46.2% (unconfirmed) – mRECIST-based ORR of 61.5% with a complete response (CR) rate of 23% – No Grade 3 or higher... Read more.
Mabwell Passes On-site GMP Inspection by Regulatory Authority of PIC/S Member Country (Jordan) for the First Time
SHANGHAI, April 20, 2026 /PRNewswire/ — Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced... Read more.